Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Yee

Showing results (301-310 of 371) with videos related to

Pageof 38
Sort By:
Scientific Reports|June 13, 2024
Accelerating the design of lattice structures using machine learningAldair E Gongora, Caleb Friedman, Deirdre K Newton, et al.
International Journal of Cancer|July 4, 2015
Associations of erythrocyte ω-3 fatty acids with biomarkers of ω-3 fatty acids and inflammation in breast tissueShuvro Roy, Theodore M Brasky, Martha A Belury, et al.
Nutrition & Metabolism|March 7, 2015
The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in miceJia-Yu Ke, Kara L Kliewer, Essam M Hamad, et al.
Oncogene|June 1, 1991
FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitroB M Kacinski, K A Scata, D Carter, et al.
Biochemical and Biophysical Research Communications|January 16, 1989
The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cellsD Yee, R E Favoni, R Lupu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markersLisa D Yee, Nita Williams, Ping Wen, et al.
ESMO Open|October 24, 2025
Phase Ib study of xentuzumab and abemaciclib in patients with advanced solid tumors and in combination with endocrine therapy in patients with advanced breast cancerD Yee, H Iwata, P LoRusso, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Randomized dose-response trial of n-3 fatty acids in hormone receptor negative breast cancer survivors- impact on breast adipose oxylipin and DNA methylation patternsDavid E Frankhouser, Todd DeWess, Isabel F Snodgrass, et al.
Environmental Research|November 6, 2012
Reducing methylmercury accumulation in the food webs of San Francisco Bay and its local watershedsJ A Davis, R E Looker, D Yee, et al.
The American Journal of Clinical Nutrition|April 27, 2025
Randomized dose-response trial of n-3 fatty acids in hormone receptor negative breast cancer survivors - impact on breast adipose oxylipin and DNA methylation patternsDavid E Frankhouser, Todd DeWees, Isabel F Snodgrass, et al.
Pageof 38

Showing results (301-310 of 371) with videos related to

Sort By:
Pageof 38
Scientific Reports|June 13, 2024
Accelerating the design of lattice structures using machine learningAldair E Gongora, Caleb Friedman, Deirdre K Newton, et al.
International Journal of Cancer|July 4, 2015
Associations of erythrocyte ω-3 fatty acids with biomarkers of ω-3 fatty acids and inflammation in breast tissueShuvro Roy, Theodore M Brasky, Martha A Belury, et al.
Nutrition & Metabolism|March 7, 2015
The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in miceJia-Yu Ke, Kara L Kliewer, Essam M Hamad, et al.
Oncogene|June 1, 1991
FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitroB M Kacinski, K A Scata, D Carter, et al.
Biochemical and Biophysical Research Communications|January 16, 1989
The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cellsD Yee, R E Favoni, R Lupu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markersLisa D Yee, Nita Williams, Ping Wen, et al.
ESMO Open|October 24, 2025
Phase Ib study of xentuzumab and abemaciclib in patients with advanced solid tumors and in combination with endocrine therapy in patients with advanced breast cancerD Yee, H Iwata, P LoRusso, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Randomized dose-response trial of n-3 fatty acids in hormone receptor negative breast cancer survivors- impact on breast adipose oxylipin and DNA methylation patternsDavid E Frankhouser, Todd DeWess, Isabel F Snodgrass, et al.
Environmental Research|November 6, 2012
Reducing methylmercury accumulation in the food webs of San Francisco Bay and its local watershedsJ A Davis, R E Looker, D Yee, et al.
The American Journal of Clinical Nutrition|April 27, 2025
Randomized dose-response trial of n-3 fatty acids in hormone receptor negative breast cancer survivors - impact on breast adipose oxylipin and DNA methylation patternsDavid E Frankhouser, Todd DeWees, Isabel F Snodgrass, et al.
Pageof 38